Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (1): 43-48.doi: 10.6040/j.issn.1671-7554.0.2019.810

Previous Articles    

High live birth rate in women with hypogonadotropic hypogonadism after treatment of in vitro fertilization

FENG Zhenhua, LI Yuanmei, CUI Wenjuan, SI Rui, SHENG Yan, ZHAO Han   

  1. Center for Reproductive Medicine, Shandong University;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics;
    Key Laboratory of Reproductive Endocrinology(Shandong University), Ministry of Education;
    Shandong Provincial Clinical Medicine Research Center for Reproductive Health, Jinan 250001, Shandong, China
  • Published:2022-09-27

PDF (PC)

19

Abstract: Objective To evaluate the outcomes of in vitro fertilization and embryo transfer(IVF-ET)in women with hypogonadotropic hypogonadism(HH). Methods The retrospective study involved 79 women with HH(HH group)who received first cycle IVF-ET during Mar. 2013 and Jan. 2017 in Center for Reproductive Medicline, Shandoug University, and 270 controls(control group)with matched age, body mass index(BMI), and normal ovarian reserve who received IVF-ET due to oviduct diseases. The outcomes of IVF-ET were compared between the two groups. Results There were no statistical differences in clinical pregnancy rate, live birth rate of fresh or frozen embryo transfer and cumulative pregnancy rate between the two groups. The early abortion rate of fresh embryo transfer(8.82% vs 10.66%), rate of ectopic pregnancy(0% vs 1.4%)and early abortion rate of frozen embryo transfer(0% vs 6.98%)were lower in HH group than in control group although no statistical significance was obtained due to limited number of samples. The HH group had more dosage of gonadotropin(Gn)［(4 163.61±1 798.98)IU vs(1872.55±759.19)IU, P<0.001］and longer Gn stimulation duration ［(14.28±2.80)d vs(11.11±1.90)d, P<0.001］ than the control group. After we adjusted the total dosage and medication time of Gn, serum HCG and other related factors, we obtained similar results. Conclusion Women with hypophysical dysfunction will get expected high live birth rate and cumulative pregnancy rate 山 东 大 学 学 报 (医 学 版)58卷1期 -冯振花,等.79例低促性腺激素性腺功能减退患者体外受精-胚胎移植结局分析 \=-after IVF-ET/FET treatment. Their clinical outcomes are comparable to those of young patients with good ovarian function.

Key words: Hypogonadotropic hypogonadism, In vitro fertilization, Cumulative pregnancy rate

CLC Number: 

  • R711.6
[1] Silveira LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism[J].J Clin Endocrinol Metab, 2013, 98(5): 1781-1788.
[2] Fechner A, Fong S, McGovern P.A review of kallmannsyndrome: genetics, pathophysiology, and clinical management[J].Obstet Gynecol Surv, 2008, 63(3):189-194.
[3] Tang RY, Chen R, Ma M,et al. Clinical characteristics of 138 Chinese female patients with idiopathic hypogonadotropic hypogonadism[J].Endocr Connect, 2017, 6(8): 800-810.
[4] 王含必,温晓晓, 汤鲜, 等. 低促性腺激素性性功能不全妇女IVF-ET治疗中的方法及疗效分析[J].中国计划生育学杂志, 2017, 25(5): 318-322. WANG Hanbi, WEN Xiaoxiao, TANG Xian, et al. Efficacy of in vitro fertilization and embryo transfer of women with hypogonadotropic hypogonadism[J]. Chinese Journal of Family Planning, 2017, 25(5): 318-322.
[5] Ghaffari F, Arabipoor A, Lankarani NB, et al. Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women[J]. Ann Saudi Med, 2013, 33(3): 235-240.
[6] Yildirim G, Ficicioglu C, Attar R, et al. Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal factor infertility[J]. Clin Exp Obstet Gynecol, 2010, 37(2):120-122.
[7] Jiang S, Kuang Y. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization[J].Clin Endocrinol(Oxf), 2018, 88(1): 77-87.
[8] Ulug U, Ben-Shlomo I, Tosun S, et al. The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program[J]. JJ Assist Reprod Genet, 2005, 22(4): 167-171.
[9] Matsumoto H. Molecular and cellular events during blastocyst implantation in the receptive uterus: clues from mouse models[J]. J Reprod Dev, 2017, 63(5): 445-454.
[10] Giakoumelou S, Wheelhouse N, Cuschieri K, et al. The role of infection in miscarriage[J]. Hum Reprod Update, 2016, 22(1): 116-133.
[11] Hipp H, Crawford S, Kawwass JF, et al. First trimester pregnancy loss after fresh and frozen in vitro fertilization cycles[J]. FertilSteril, 2016, 105(3): 722-728.
[12] Zhang YN, Zhang YS, Yu Q, et al. Higher prevalence of endometrial polyps in infertile patients with endometriosis[J]. Gynecol Obstet Invest, 2018, 83(6): 558-563.
[13] Krause BT, Ohlinger R, Haase A. Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review[J]. BBiologics, 2009, 3(3): 337-347.
[14] Yilmaz S, Ozgu-Erdinc AS, Yumusak O, et al. The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization[J]. Syst Biol Reprod Med, 2015, 61(4): 228-232.
[15] Pezzuto A, Ferrari B, Coppola F, et al. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serumLH levels[J]. Gynecol Endocrinol, 2010, 26(2): 118-124.
[16] Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction[J]. Hum Reprod, 2000, 15(5): 1003-1008.
[17] Wong PC, Qiao J, Ho C, et al. Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective[J]. Reprod Biomed Online, 2011, 23(1):81-90.
[18] Kuroda K, Ezoe K, Kato K, et al. Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism[J]. J Obstet Gynaecol Res, 2018, 44(5): 922-928.
[19] Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2017, 1:CD012103.
[20] Roy TK, Bradley CK, Bowman MC, et al. Single-embryo transfer of vitrified-warmed blastocysts yields equivalent live-birth rates and improved neonatal outcomes compared with fresh transfers[J]. Fertil Steril, 2014, 101(5): 1294-1301.
[21] Kobayashi R, Terakawa J, Omatsu T, et al. The window of implantation is closed by estrogen via insulin-like growth factor 1 pathway[J]. J Reprod Infertil, 2017, 18(2): 231-241.
[22] Edgar DH, Whalley KM, Mills JA. Effects of high-dose and multiple-dose gonadotropin stimulation on mouse oocyte quality as assessed by preimplantation development following in vitro fertilization[J]. J In Vitro Fert Embryo Transf, 1987, 4(5):273-276.
[23] Sato F, Marrs RP. The effect of pregnant mare serum gonadotropin on mouse embryos fertilized in vivo or in vitro[J]. J In Vitro Fert Embryo Transf, 1986, 3(6): 353-357.
[24] Friedler S, Meltzer S, Saar-Ryss B, et al. An upper limit of gonadotropin dose in patients undergoing ART should be advocated[J]. Gynecol Endocrinol, 2016, 32(12): 965-969.
[25] Lewit N, Kol S. The low responder female IVF patient with hypogonadotropic hypogonadism: do not give up! [J]. Fertil Steril, 2000, 74(2): 401-402.
[1] Lei YAN,Zijiang CHEN. Treatment of adenomyosis complicated with infertility [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 43-47.
[2] WU Richao, LIU Hong, WANG Ze, GAO Shanshan, LI Xiufang, SHI Yuhua. Pregnancy outcomes of in vitro fertilization-intracytoplasmic sperm injection-embryo transfer in women 40 years and above [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 35-39.
[3] CHEN Wei, GUO Qingqing, XU Jin, FANG Yuan, SUN Mei, SHENG Yan. A comparative analysis of the effects of natural cycle combined with luteal ovarian stimulation and dual ovarian stimulation [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 61-66.
[4] Xiaohui DENG,Ling GUO. Applications and progress of immunotherapy in repeated implantation failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 32-37.
[5] WU Xiaolin, LI Ping. Effect of Gn stimulation duration on pregnancy outcome of IVF-ET in long GnRHa protocol [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 32-37.
[6] SUN Mei, CUI Wenjuan. Risk factors affecting fertility and strategies for advanced age fertility [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 23-28.
[7] YU Na, GUO Qingqing, SUN Mei, SHENG Yan, MA Zengxiang, QIN Yingying. Clinical outcomes of IVF/ICSI-ET after thyroid cancer surgical treatment [J]. Journal of Shandong University (Health Sciences), 2018, 56(9): 54-58.
[8] CHEN Shiling, ZHOU Xingyu. Clinical research advances on premature ovarian insufficiency [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 1-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd